Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MEthylphenidate in ADHD - Addiction(s) Comorbidity: Value of Adding a Cognitive Remediation Program to Improve Short- and Medium-term Therapeutic Response

NCT06906328 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT06906328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06906328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MEthylphenidate in ADHD - Addiction(s) Comorbidity: Value of Adding a Cognitive Remediation Program to Improve Short- and Medium-term Therapeutic Response
Lead sponsor
Nantes University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
December 11, 2025
Completion date
December 11, 2029
Enrollment
248 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

adhd-add